Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17146800 | 0.96 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMKMT2APTGER4 | |
| SCHEMBL25880434 | 0.91 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2APTGER4 | |
| SCHEMBL21579260 | 0.90 | KDM4E (0.35) | L3MBTL1KDM4EATM | |
| SCHEMBL24078682 | 0.89 | ATM (0.39) | L3MBTL1KDM4EATMHDAC4ALDH1A1 | |
| SCHEMBL20444344 | 0.89 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMKMT2APTGER4 | |
| SCHEMBL20857851 | 0.88 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMKMT2APTGER4 | |
| SCHEMBL21473029 | 0.88 | KDM4E (0.43) | L3MBTL1KDM4EATMKMT2APTGER4 | |
| SCHEMBL17265062 | 0.88 | KDM4E (0.38) | L3MBTL1KDM4EATMPTGER4ALDH1A1 | |
| SCHEMBL17704989 | 0.88 | KDM4E (0.38) | L3MBTL1KDM4EATMPTGER4 | |
| SCHEMBL25816067 | 0.87 | KDM4E (0.38) | L3MBTL1KDM4EATMHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-11569449-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-31 | — | — | US | disclosed |
| US-20210336149-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
| WO-2021065772-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE | 出光興産株式会社 | 2021-04-08 | — | — | WO | disclosed |
| EP-3723149-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-10680181-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-09 | — | — | US | disclosed |
| US-10672989-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-02 | — | — | US | disclosed |
| US-10658594-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20190355914-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-11-21 | — | — | US | disclosed |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20190194215-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10249832-B1 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2019-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | L3MBTL1 1480/4885KDM4E 3303/4885ATM 1785/4885 |
| US-10249832-B1 | Organic electroluminescence device and novel compound | OR10J3, KCNH3, OR51E2 | L3MBTL1 179/4885KDM4E 2905/4885ATM 4040/4885 |
| US-10658594-B2 | Organic electroluminescence device and novel compound | OR10J3, OR51E2, TRPC6 | L3MBTL1 679/4885KDM4E 2508/4885ATM 2850/4885 |
| US-10680181-B2 | Organic electroluminescence device and novel compound | PIEZO1, TMEM109, OXA1L | L3MBTL1 1480/4885KDM4E 3303/4885ATM 1785/4885 |
| US-20190194215-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | OR10J3, OR51E2, TRPC6 | L3MBTL1 679/4885KDM4E 2508/4885ATM 2850/4885 |
| US-10672989-B2 | Organic electroluminescence device and novel compound | LEF1, OR10J3, LUC7L2 | L3MBTL1 1038/4885KDM4E 3077/4885ATM 3196/4885 |
| US-20190355914-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | L3MBTL1 1480/4885KDM4E 3303/4885ATM 1785/4885 |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | KCNN4, OR10J3, KCNN2 | L3MBTL1 1045/4885KDM4E 1771/4885ATM 3492/4885 |
| US-11569449-B2 | Organic electroluminescence device and novel compound | PIEZO1, TMEM109, OXA1L | L3MBTL1 1480/4885KDM4E 3303/4885ATM 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.